Historial de carrera de James Cullem
Antiguos cargos conocidos de James Cullem.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Miembro de la Junta | 01/07/2022 | 08/12/2023 |
| Director Ejecutivo | 01/06/2022 | 08/12/2023 | |
| Corporate Officer/Principal | 01/10/2019 | 01/06/2022 | |
| ALLARITY THERAPEUTICS, INC. | Director/Miembro de la Junta | 07/07/2022 | 08/12/2023 |
| Director Ejecutivo | 29/06/2022 | 08/12/2023 | |
| Corporate Officer/Principal | 06/04/2021 | 29/06/2022 | |
Oncology Venture Sweden AB
 Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Corporate Officer/Principal | 01/01/2015 | - |
Estadísticas
Internacional
| Dinamarca | 3 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- James Cullem
- Experiencia
